Aldo Habib

Aldo Habib serves as CEO at Parabolic Drugs. Parabolic Drugs operates in the pharmaceuticals sector with approximately 310.0 employees. The company is headquartered in Decatur, Georgia. Parabolic Drugs generates annual revenue of 12500000.0.

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • 2,842 executive contacts are available in Georgia.
• • Our database includes 201,469 c suite-level executives.

Nginx WordPress.org Google Font API Mobile Friendly Remote

antibiotic apis & intermediates non antibiotic apis custom synthesis & research hpais finished dosage formulations pharmaceutical manufacturing parabolic drugs pharmaceutical manufacturer api manufacturing active pharmaceutical ingredients contract research custom synthesis research & development antibiotic apis non-antibiotic apis pharmaceutical exporter global marketing regulatory affairs quality control gmp facility eu gmp korean fda japanese pmda ohsas certification iso certification intellectual property rights dossier support pharmaceutical products finished formulations therapeutic segments supply chain management custom research integrated services medicinal chemistry analytical development impurity analysis chiral synthesis hydrogenation reactions process development critical quality attributes environmental initiatives corporate governance investment relations financial performance manufacturing capabilities market presence strategic partnerships health & safety client relationships complex chemistry operational efficiencies regulatory documentation therapeutic areas sustainable practices pharma collaborations pharmaceuticals medical logistics & supply chain

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

LJ

Lars Jensen CEO at A-apoteket

TL

Tien Lee CEO at Aardvark Therapeutics, Inc.

Outreach Guidance — pharmaceuticals Sector

Executives like Aldo Habib in the pharmaceuticals sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Parabolic Drugs.

Aldo Habib's Position in the MessageCEO Database

• •Aldo Habib is 1 of 1 verified executive contact we track at Parabolic Drugs.
• •1,240 verified executive contacts in pharmaceuticals are in the MessageCEO database.
• •2,643 verified executive contacts in Georgia are in the database.
• •8 verified contacts work at pharmaceuticals companies in the 310.0 employee range (same size as Parabolic Drugs).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated May 2026.

How do I reach Aldo Habib directly?

Aldo Habib's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at Parabolic Drugs. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Aldo Habib work for?

Aldo Habib is CEO at Parabolic Drugs, a company in the pharmaceuticals sector with 310.0 employees. The company is based in Decatur, Georgia.

Can I pitch or sell to Aldo Habib?

As CEO at Parabolic Drugs, Aldo Habib is a key decision-maker in the pharmaceuticals sector. MessageCEO Pro gives you verified email to reach Aldo Habib directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Aldo Habib in?

Aldo Habib works in the pharmaceuticals industry as CEO at Parabolic Drugs. MessageCEO provides verified contact information for executives across all major industries.

Is Aldo Habib's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Aldo Habib's profile is kept up-to-date with the latest available information.

Last updated: May 25, 2026